Search for: "MERCK " Results 641 - 660 of 3,309
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Oct 2016, 1:56 pm by Tom Lamb
Here is a list of direct-acting antivirals currently available in the US: Daklinza (daclatasvir) -- Bristol-Myers SquibbEpclusa (sofosbuvir and velpatasvir) -- Gilead SciencesHarvoni (ledipasvir and sofosbuvir) -- Gilead SciencesOlysio (simeprevir) -- JanssenSovaldi (sofosbuvir) -- Gilead SciencesTechnivie (ombitasvir and paritaprevir and ritonavir) -- AbbvieViekira Pak (dasabuvir and ombitasvir and paritaprevir and ritonavir) -- AbbvieViekira Pak XR (dasabuvir and ombitasvir and paritaprevir and… [read post]
21 Sep 2016, 5:02 pm by Sabrina I. Pacifici
Since Mylan acquired the EpiPen from Merck in 2007, the company has increased the list price for a pack of two EpiPens nearly 550%, from $94 in January 2007 to $609 in May 2016. [read post]
20 Sep 2016, 1:03 am by Vanessa Rieu
Dr Adair noted that the idea for granting such declarations dates back to the Arrow Generics v Merck case, concerning alendronate, about 10 years ago. [read post]
17 Aug 2016, 10:38 am by Kelly Phillips Erb
Similarly, Ford Motor Company repatriated around $850 million under the holiday and then laid off about 10,000 U.S. workers in 2005; Merck repatriated $15.9 billion and announced layoffs of 7,000 workers in 2005). [read post]
29 Jul 2016, 1:30 pm
 This term has been no different, but my, how they have ended in a dramatic fashion with....drum roll please...a reference to the CJEU from Mr Justice Arnold on the SPC Regulation in Merck Sharp & Dohme v Comptroller-General of Patents [2016] EWHC 1896.The problem and the questions to be referred What do you do if your patent is about to expire, but despite notice that Member States have agreed to grant your marketing authorization (MA) under the decentralized procedure, a MS… [read post]
13 Jun 2016, 7:09 am by Editors
In a decision that will certainly be appealed, a judge ruled that in-house lawyer misconduct will result in a company losing out on quite a hefty sum: “A U.S. judge on Monday found a pattern of misconduct by Merck & Co including lying under oath and other unethical practices, freeing Gilead Sciences Inc from paying any damages for infringing Merck’s patents with its lucrative treatments for hepatitis C…The dramatic ruling comes after a federal jury… [read post]
8 Jun 2016, 5:57 am by Staci Zaretsky
This in-house Merck patent prosecutor must be in a very bad place right now. [read post]